Literature DB >> 35875289

Antineutrophil Cytoplasmic Antibody (ANCA)-Associated Renal Vasculitis After COVID-19 Infection: A Case Report.

Saurabh Kataria1,2,3, Sylvette Rogers4, Haleema Sadia5, Tooba Ali6, Hasham M Qureshi7, Shehar Bano8, Chinyere L Anigbo9, Romil Singh10.   

Abstract

Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis is a class of autoimmune diseases that can cause kidney failure because of mononuclear cell infiltration and the destruction of small and medium-sized blood vessels. Coronavirus disease 2019 (COVID-19) may trigger or exacerbate autoimmune diseases. We present a case of ANCA-associated vasculitis in a patient with rheumatoid arthritis after a COVID-19 infection, who presented with intermittent hemoptysis and dyspnea and was diagnosed with COVID-19 pneumonia three weeks ago. Her clinical, radiological, and serological picture was concerned with pulmonary-renal syndrome. Her serum was positive for antinuclear antibody and ANCAs, and renal biopsy showed pauci-immune crescentic glomerulonephritis. She was diagnosed clinicopathologically with pauci-immune glomerulonephritis in the setting of rheumatoid arthritis (RA) after a COVID-19 infection. Her condition improved after she was treated with rituximab and pulse dose methylprednisolone.
Copyright © 2022, Kataria et al.

Entities:  

Keywords:  anca associated vasculitis; antineutrophil cytoplasmic antibody (anca); coronavirus disease; covid-19; rheumatoid arthritis

Year:  2022        PMID: 35875289      PMCID: PMC9298682          DOI: 10.7759/cureus.26111

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  14 in total

1.  Newly Diagnosed Glomerulonephritis During COVID-19 Infection Undergoing Immunosuppression Therapy, a Case Report.

Authors:  Firouzeh Moeinzadeh; Majid Dezfouli; Azar Naimi; Shahrzad Shahidi; Hazhir Moradi
Journal:  Iran J Kidney Dis       Date:  2020-05       Impact factor: 0.892

Review 2.  Vasculitides associated with infections, immunization, and antimicrobial drugs.

Authors:  T Somer; S M Finegold
Journal:  Clin Infect Dis       Date:  1995-04       Impact factor: 9.079

3.  Immune-mediated glomerular diseases: new basic concepts and clinical implications.

Authors:  Ulf Panzer; Tobias B Huber
Journal:  Cell Tissue Res       Date:  2021-08-31       Impact factor: 4.051

Review 4.  [Kidney involvement in rheumatoid arthritis].

Authors:  A Icardi; P Araghi; M Ciabattoni; U Romano; P Lazzarini; G Bianchi
Journal:  Reumatismo       Date:  2003

Review 5.  Vasculitis related to viral and other microbial agents.

Authors:  Gim Gee Teng; W Winn Chatham
Journal:  Best Pract Res Clin Rheumatol       Date:  2015-06-11       Impact factor: 4.098

6.  Prevalence of overlap of antineutrophil cytoplasmic antibody associated vasculitis with systemic autoimmune diseases: an unrecognized example of poliautoimmunity.

Authors:  Eduardo Martín-Nares; Diego Zuñiga-Tamayo; Andrea Hinojosa-Azaola
Journal:  Clin Rheumatol       Date:  2018-07-14       Impact factor: 2.980

7.  2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides.

Authors:  J C Jennette; R J Falk; P A Bacon; N Basu; M C Cid; F Ferrario; L F Flores-Suarez; W L Gross; L Guillevin; E C Hagen; G S Hoffman; D R Jayne; C G M Kallenberg; P Lamprecht; C A Langford; R A Luqmani; A D Mahr; E L Matteson; P A Merkel; S Ozen; C D Pusey; N Rasmussen; A J Rees; D G I Scott; U Specks; J H Stone; K Takahashi; R A Watts
Journal:  Arthritis Rheum       Date:  2013-01

Review 8.  ANCA-associated vasculitis after COVID-19.

Authors:  Tugba Izci Duran; Ercan Turkmen; Melda Dilek; Hayriye Sayarlioglu; Nurol Arik
Journal:  Rheumatol Int       Date:  2021-06-07       Impact factor: 2.631

9.  Antineutrophil Cytoplasmic Antibody-Associated Glomerulonephritis in a Case of Scleroderma After Recent Diagnosis With COVID-19.

Authors:  Mojgan Jalalzadeh; Julio C Valencia-Manrique; Noella Boma; Ashok Chaudhari; Shobhana Chaudhari
Journal:  Cureus       Date:  2021-01-04

10.  De Novo ANCA-Associated Vasculitis With Glomerulonephritis in COVID-19.

Authors:  Nupur N Uppal; Nina Kello; Hitesh H Shah; Yuriy Khanin; Ivan Ramirez De Oleo; Edward Epstein; Purva Sharma; Christopher P Larsen; Vanesa Bijol; Kenar D Jhaveri
Journal:  Kidney Int Rep       Date:  2020-08-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.